Qelbree - New Treatment for ADHD | ADHD | Episode 48
Dr. John Kruse Dr. John Kruse
4.66K subscribers
14,328 views
0

 Published On Jun 14, 2021

The first new FDA-approved non-stimulant for ADHD in 12 years, viloxazine has some interesting similarities to other agents, but has a unique pharmacologic profile as a Serotonin and Norepinephrine Modulatory Agent (SNMA).

Join the conversation on FB:   / drjohnkruse  

show more

Share/Embed